Anson Funds Management LP Spero Therapeutics, Inc. Transaction History
Anson Funds Management LP
- $839 Million
- Q3 2024
A detailed history of Anson Funds Management LP transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Anson Funds Management LP holds 3,750,450 shares of SPRO stock, worth $3.53 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
3,750,450
Previous 3,750,450
-0.0%
Holding current value
$3.53 Million
Previous $5.03 Million
-0.0%
% of portfolio
0.6%
Previous 0.6%
Shares
7 transactions
Others Institutions Holding SPRO
# of Institutions
49Shares Held
13.9MCall Options Held
200Put Options Held
200-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.66 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$1.27 Million14.54% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$1.01 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny975KShares$916,1730.0% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$836,5800.08% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $33M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...